Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Foundayo
Pharma
The Oral GLP-1 Tracker: Lilly’s Foundayo launch remains ‘muted’
Fierce Pharma's weekly Oral GLP-1 Tracker monitors prescription trends for Novo Nordisk's Wegovy pill and Eli Lilly's Foundayo.
Angus Liu
,
Kevin Dunleavy
,
Fraiser Kansteiner
Jul 10, 2026 2:30pm
In Europe, Lilly exec says MFN will affect Foundayo launch
Jun 24, 2026 11:20am
'Familiarity' with oral Wegovy has triggered its quick uptake
Jun 18, 2026 11:15am
ADA: Lilly's Foundayo pads case against semaglutide in diabetes
Jun 8, 2026 3:42pm
CVS will cover Eli Lilly obesity products Zepbound and Foundayo
May 28, 2026 11:20am
Trump bought stock in drugmaker as admin boosted its obesity drugs
May 19, 2026 8:47am
